We are monitoring the impact of COVID-19 on Acne Medication Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 6557
Share on
Share on

Global Acne Medication Market Size, Share, Trends, Growth Analysis Report - Segmented By Type, Route of Administration, Drug Class and Region – Industry Forecast | 2019 - 2024

Pulished: August, 2019
ID: 6557
Pages: 175

Industry Analysis

The size of the global acne medication market was worth USD 8.3 Billion in 2019 and is growing at a CAGR of 4.9% from 2019 to 2024.

Acne is the most common skin disorder that is caused by the pimples, blackheads, oily skin which is caused by dead skin cells, blacked fail follicles. Acne majorly witnesses in adults and teenagers and can be treatable through Topical treatments, Oral antibiotics, Oral contraceptive pills, Isotretinoin capsules and other treatments.

MARKET DRIVERS

Growing incidences of acne are primarily driving the market growth.

According to the National Center for Biotechnology Information, acne is affecting around 9.4% of the population worldwide.

According to the American Academy of Dermatology, around 50 million in the United States are affecting with acne problems per year. Noticed, the majority of the cases are occurring in teenagers and adults. Also stated, acne may affect at any point of age and continue to 30 to 40 years of age. More than 1.2 Billion USD business happened to acne treatments and medications in the United States alone in the year 2013.

Additionally, Unhealthy lifestyle changes which may cause pimples and blackheads in the majority of the youth population is one of the significant factor accelerating market growth. Many of the acne drugs are readying to receive approval. It clears the competition in the market in the coming years to turn fiercer.

Majority of the female population around the world are much concerned about their facial problems. The growing desire of having beautiful looks, especially in youth is another crucial factor driving market growth. Increase of common long-term skin problems that are growing throughout the world is one of the factors that drive the market. Pollution is also one of the factors that increase skin diseases that accelerate acne medication treatment in the market.

MARKET RESTRAINTS

Adverse effects with the intake of medicines for the prevention of pimples, blackheads and oily skin are one of the factors that restrain the acne medication market growth. Availability of existing acne treatments like laser therapy is one of the essential elements that hamper market growth.

REPORT COVERAGE

Report Metric

Details

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Route of Administration, Drug  Class and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Challenges, Restraints, Opportunities, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the Global Acne Medication Market has been segmented and sub-segmented based on the type, route of administration, drug class and region.

Acne Medication Market Analysis – By Type:

  • OTC drugs
  • Prescription drugs

Based on type, the Over the counter (OTC) drugs to share the maximum revenue during the period. It is, due to the increasing occurrence of the patient population in making use of these OTC drugs as they are suitable for purchasing and cheap is boosting up the market.

Prescription drugs are likely to have a steady growth of 6.3% during the period. Antibiotics are a kind of prescription products combined with a combination of topical retinoid which drives up the market growth.

Acne Medication Market Analysis – By Route of Administration:

  • Topical
  • Oral

Based on the Route of Administration, the topical segment is growing at a CAGR of 3.6%. High availability of products and the success rate and very less adverse effects are driving the growth of this segment.

Acne Medication Market Analysis – By Drug Class:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Anti-Microbial
  • Combination Drugs
  • Hormonal Agents
  • Oral Retinoid
  • Topical Retinoid

Based on drug class, the Anti-inflammatory segment holds a significant share of the market revenue. It is likely to maintain its leading position during the period.

Acne Medication Market Analysis – By Region:

  • North America
  • Europe
  • APAC
  • Latin America
  • MEA

In 2019, the North America region had the largest market share in the global acne medication market and likely to continue its domination throughout the forecast period. Within North America, the United States held the majority of the shares. It is due to the growing usage of skincare products, early approval of acne medication products and prescription medicines usage.

Europe stands at the second position in leading the majority of the shares in the global acne medication market.

Asia-Pacific region is likely to grow with a highest CAGR value of 5.6% due to the increase of ability to afford, increase in the amount spent on healthcare, and growing awareness for the safety acne medication products.

In the Middle East & Africa, the Anti-Inflammatory segment is likely to show significant growth during the period. This Anti-inflammatory acne segment is the most appealing in the Middle East & African region of Acne treatment market during the period.

Top companies in the market

Some of the major companies dominating the market, by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

Zydus Cadila, one of the contributors towards the acne medication market, has received the acceptance from the U.S. FDA a health regulator for its product Clindamycin Phosphate and Benzoyl Peroxide gel that helps in treating the patients suffering from acne. In this, Clindamycin Phosphate is used to get rid of pimples and stops the growth of acne, causing bacteria. Besides, Benzoyl Peroxide is to prevent the growth of the bacteria and reduces oil production in the skin.

Bausch Health Company, a renowned name in the pharmaceutical industry, has received the FDA approval for their product called ARAZLO. It is a prescription medicine that helps to treat acne vulgaris.

GlaxoSmithKline received the acceptance for marketing its product Fabior foam for the removal of pimples and blackheads for the people who are suffering from acne. This Fabior has got the U.S. FDA for treating patients who are aged 12 or above with medium to significant extent acne.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 OTC drugs

                                5.1.3 Prescription drugs

                                5.1.4  Y-o-Y Growth Analysis, By type     

                                5.1.5  Market Attractiveness Analysis, By type   

                                5.1.6 Market Share Analysis, By type      

                5.2 Route of administration                        

                                5.2.1 Introduction           

                                5.2.2 Topical      

                                5.2.3 Oral            

                                5.2.4 Y-o-Y Growth Analysis, By route of administration

                                5.2.5 Market Attractiveness Analysis, By route of administration              

                                5.2.6 Market Share Analysis, By route of administration

                5.3 Drug class                    

                                5.3.1 Introduction           

                                5.3.2 Antibiotics               

                                5.3.3 Anti-inflammatory drugs   

                                5.3.4 Anti-microbials      

                                5.3.5 Combination drugs              

                                5.3.6 Hormonal agents  

                                5.3.7 Oral retinoids         

                                5.3.8 Topical retinoids   

                                5.3.7 Y-o-Y Growth Analysis, By drug class            

                                5.3.8  Market Attractiveness Analysis, By drug class         

                                5.3.9  Market Share Analysis, By drug class          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By type

                                                6.1.3.3 By route of administration

                                                6.1.3.4 By drug class

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By type

                                                6.1.4.3 By route of administration

                                                6.1.4.4 By drug class

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By type

                                                6.1.5.3 By route of administration

                                                6.1.5.4 By drug class

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline plc                

                8.3 Novartis AG                

                8.4 Merck & Co. Inc                        

                8.5 Amgen, Inc.                

                8.6 Abbott Laboratories                               

                8.7 Eli Lilly and Company                              

                8.8 Daiichi Sankyo Company, Ltd                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of route, by Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Global Acne Medication Market By Region, From 2019-2024 ( USD Billion )
  2. Global Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  3. Global Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  4. Global Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  5. Global Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  6. Global Topical Market By Region, From 2019-2024 ( USD Billion )
  7. Global Oral Market By Region, From 2019-2024 ( USD Billion )
  8. Global Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  9. Global Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  10. Global Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  11. Global Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  12. Global Combination Market By Region, From 2019-2024 ( USD Billion )
  13. Global Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  14. Global Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  15. Global Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  16. North America Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  17. North America Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  18. North America Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  19. North America Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  20. North America Topical Market By Region, From 2019-2024 ( USD Billion )
  21. North America Oral Market By Region, From 2019-2024 ( USD Billion )
  22. North America Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  23. North America Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  24. North America Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  25. North America Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  26. North America Combination Market By Region, From 2019-2024 ( USD Billion )
  27. North America Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  28. North America Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  29. North America Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  30. United States Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  31. United States Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  32. United States Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  33. Canada Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  34. Canada Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  35. Canada Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  36. Europe Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  37. Europe Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  38. Europe Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  39. Europe Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  40. Europe Topical Market By Region, From 2019-2024 ( USD Billion )
  41. Europe Oral Market By Region, From 2019-2024 ( USD Billion )
  42. Europe Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  43. Europe Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  44. Europe Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  45. Europe Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  46. Europe Combination Market By Region, From 2019-2024 ( USD Billion )
  47. Europe Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  48. Europe Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  49. Europe Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  50. U.K. Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  51. U.K. Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  52. U.K. Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  53. Germany Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  54. Germany Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  55. Germany Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  56. France Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  57. France Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  58. France Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  59. Italy Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  60. Italy Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  61. Italy Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  62. Spain Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  63. Spain Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  64. Spain Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  65. Asia Pacific Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  66. Asia Pacific Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  67. Asia Pacific Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  68. Asia Pacific Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  69. Asia Pacific Topical Market By Region, From 2019-2024 ( USD Billion )
  70. Asia Pacific Oral Market By Region, From 2019-2024 ( USD Billion )
  71. Asia Pacific Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  72. Asia Pacific Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  73. Asia Pacific Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  74. Asia Pacific Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  75. Asia Pacific Combination Market By Region, From 2019-2024 ( USD Billion )
  76. Asia Pacific Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  77. Asia Pacific Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  78. Asia Pacific Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  79. Japan Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  80. Japan Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  81. Japan Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  82. China Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  83. China Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  84. China Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  85. India Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  86. India Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  87. India Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  88. Australia Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  89. Australia Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  90. Australia Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  91. South Korea Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  92. South Korea Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  93. South Korea Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  94. Latin America Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  95. Latin America Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  96. Latin America Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  97. Latin America Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  98. Latin America Topical Market By Region, From 2019-2024 ( USD Billion )
  99. Latin America Oral Market By Region, From 2019-2024 ( USD Billion )
  100. Latin America Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  101. Latin America Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  102. Latin America Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  103. Latin America Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  104. Latin America Combination Market By Region, From 2019-2024 ( USD Billion )
  105. Latin America Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  106. Latin America Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  107. Latin America Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  108. Brazil Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  109. Brazil Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  110. Brazil Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  111. Argentina Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  112. Argentina Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  113. Argentina Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  114. Mexico Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  115. Mexico Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  116. Mexico Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  117. Rest of Latin America Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  118. Rest of Latin America Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  119. Rest of Latin America Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  120. Middle East and Africa Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  121. Middle East and Africa Otc drugs Market By Region, From 2019-2024 ( USD Billion )
  122. Middle East and Africa Prescription drugs Market By Region, From 2019-2024 ( USD Billion )
  123. Middle East and Africa Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  124. Middle East and Africa Topical Market By Region, From 2019-2024 ( USD Billion )
  125. Middle East and Africa Oral Market By Region, From 2019-2024 ( USD Billion )
  126. Middle East and Africa Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  127. Middle East and Africa Antibiotics Market By Region, From 2019-2024 ( USD Billion )
  128. Middle East and Africa Anti-inflammatory  Market By Region, From 2019-2024 ( USD Billion )
  129. Middle East and Africa Antimicrobials Market By Region, From 2019-2024 ( USD Billion )
  130. Middle East and Africa Combination Market By Region, From 2019-2024 ( USD Billion )
  131. Middle East and Africa Hormonla agents Market By Region, From 2019-2024 ( USD Billion )
  132. Middle East and Africa Oral retinoids Market By Region, From 2019-2024 ( USD Billion )
  133. Middle East and Africa Topical retinoids Market By Region, From 2019-2024 ( USD Billion )
  134. Middle East Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  135. Middle East Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  136. Middle East Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )
  137. Africa Acne Medication Market By Type, From 2019-2024 ( USD Billion )
  138. Africa Acne Medication Market By Route of administration, From 2019-2024 ( USD Billion )
  139. Africa Acne Medication Market By Drug class, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample